BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15124685)

  • 21. The expanding role of arsenic in acute promyelocytic leukemia.
    Tallman MS
    Semin Hematol; 2008 Jul; 45(3 Suppl 2):S25-9. PubMed ID: 18760708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate.
    Ohno R; Asou N; Ohnishi K
    Leukemia; 2003 Aug; 17(8):1454-63. PubMed ID: 12886231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.
    de Botton S; Fawaz A; Chevret S; Dombret H; Thomas X; Sanz M; Guerci A; San Miguel J; de la Serna J; Stoppa AM; Reman O; Stamatoulas A; Fey M; Cahn JY; Sotto JJ; Bourhis JH; Parry A; Chomienne C; Degos L; Fenaux P
    J Clin Oncol; 2005 Jan; 23(1):120-6. PubMed ID: 15534358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of acute promyelocytic leukemia in the very elderly: case report and review of the literature.
    Sham RL; Tallman MS
    Leuk Res; 2004 Dec; 28(12):1347-50. PubMed ID: 15475077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of relapsed or refractory acute promyelocytic leukemia.
    Tallman MS
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):57-65. PubMed ID: 17336255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoids in pediatric onco-hematology: the model of acute promyelocytic leukemia and neuroblastoma.
    Masetti R; Biagi C; Zama D; Vendemini F; Martoni A; Morello W; Gasperini P; Pession A
    Adv Ther; 2012 Sep; 29(9):747-62. PubMed ID: 22941525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
    Gupta V; Yi QL; Brandwein J; Lipton JH; Messner HA; Schuh AC; Wells RA; Minden MD
    Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Managing acute promyelocytic leukemia without conventional chemotherapy: is it possible?
    Park JH; Tallman MS
    Expert Rev Hematol; 2011 Aug; 4(4):427-36. PubMed ID: 21801134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical roundtable monograph. Early death in patients with acute promyelocytic leukemia.
    Tallman M; Lo-Coco F; Kwaan H; Sanz M; Gore S
    Clin Adv Hematol Oncol; 2011 Feb; 9(2):1-16. PubMed ID: 22379665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is the role of arsenic in newly diagnosed APL?
    Tallman MS
    Best Pract Res Clin Haematol; 2008 Dec; 21(4):659-66. PubMed ID: 19041605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center.
    Xin L; Wan-jun S; Zeng-jun L; Yao-zhong Z; Yun-tao L; Yan L; Chang-chun W; Qiao-chuan L; Ren-chi Y; Ming-zhe H; Jian-xiang W; Lu-gui Q
    Leuk Res; 2007 Jun; 31(6):765-71. PubMed ID: 17007927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of autologous transplantation for acute myeloid leukemia in first and second remission.
    Linker C
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):77-84. PubMed ID: 17336257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiating therapy in acute myeloid leukemia.
    Tallman MS
    Leukemia; 1996 Jun; 10 Suppl 2():s33-8. PubMed ID: 8649051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is acute promyelocytic leukemia a curable disease? Treatment strategy for a long-term survival.
    Degos L
    Leukemia; 1994 Jun; 8(6):911-3. PubMed ID: 8207982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose antimetabolite-based chemotherapy.
    Dvorak CC; Sanders RP; Dahl GV; Donaldson SS; Razzouk BI
    Pediatr Blood Cancer; 2007 May; 48(5):582-5. PubMed ID: 16123994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Leukemogenesis and therapy of acute promyelocytic leukemia: from the worse to the most favorable subtype of acute myeloid leukemia].
    KorĂ­stek Z; Mayer J
    Vnitr Lek; 2008; 54(7-8):701-27. PubMed ID: 18780571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two cases of therapy-related acute promyelocytic leukemia (t-APL) after mantle cell lymphoma and gestational trophoblastic disease.
    Au WY; Ma SK; Chung LP; Chim CS; Kwong YL
    Ann Hematol; 2002 Nov; 81(11):659-61. PubMed ID: 12454706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
    Al Bahar S; Pandita R; Bavishi K; Kreze O
    Indian J Cancer; 2004; 41(3):125-8. PubMed ID: 15472411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of acute promyelocytic leukemia by retinoids.
    Fenaux P; Wang ZZ; Degos L
    Curr Top Microbiol Immunol; 2007; 313():101-28. PubMed ID: 17217041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematopoietic cell transplantation in acute promyelocytic leukemia: a comprehensive review.
    Kharfan-Dabaja MA; Abou Mourad YR; Fernandez HF; Pasquini MC; Santos ES
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):997-1004. PubMed ID: 17697961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.